|Grant Affiliation:||Weiss: Protection by Neutralizing Antibodies|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2012-12-05|
|Study Made Public:||2013-11-08|
weiss_AB-labeling 96ZM test_PA_400 Study
CAVD 400 is a monoclonal antibody screening study.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No integrated data is available for this study.
No non-integrated data is available for this study.